Method for improving activity of NK cells after cryopreservation

Through improved frozen storage solution and frozen storage steps, the activity and killing effect of NK cells after frozen storage is improved by using AIM-V culture medium, calf serum and other ingredients, and the activity reduction and killing caused by existing frozen storage methods are solved. The problem of degradation of ability.

CN118975551APending Publication Date: 2024-11-19广东壹加再生医学研究院有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411380399.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing NK cell freezing methods lead to large damage to frozen storage, reducing the resuscitation rate and killing activity after resuscitation, which affects the quality of cells' treatment.

Method used

Provided an improved frozen storage solution containing AIM-V medium, calf serum, glycerin, sodium alginate, dimethyl sulfoxide, human albumin, thremella polysaccharide and 5-methylenol-3-ol, by Specific concentration ratios and freezing steps to improve the activity of NK cells after freezing.

Benefits of technology

It effectively improves the activity and killing effect of NK cells after frozen storage, ensures the quality of cells after frozen storage, and avoids the decrease in cell activity and loss of lethality.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of cell cryopreservation. The invention provides a method for improving activity of NK cells after cryopreservation, the method relates to a cryopreservation solution, the cryopreservation solution is based on an AIM-V culture medium, calf serum and glycerol, and the cryopreservation solution also contains the following raw materials in concentration: 5-15g / L of sodium alginate, 80-120g / L of dimethyl sulfoxide, 20-30mg / L of human serum albumin, 8-12mg / L of tremella polysaccharide and 20-30mg / L of 5-glutenin-3-ol. The NK cell cryopreservation liquid provided by the invention is combined with the NK cell cryopreservation method for use, so that the activity of the cryopreserved NK cells can be effectively improved, and the killing effect of the cryopreserved NK cells is ensured.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of cell cryopreservation technology, and in particular to a method for improving the activity of NK cells after cryopreservation. Background Technology

[0002] NK cells, or natural killer cells, are important immune cells in the body. They are not only involved in anti-tumor, anti-viral infection, and immune regulation, but also participate in hypersensitivity reactions and the development of autoimmune diseases in certain situations. They can recognize target cells and kill mediators. NK cells originate from bone marrow lymphoid stem cells, and their differentiation and development depend on the bone marrow and thymus microenvironment. They are mainly distributed in the bone marrow, peripheral blood, liver, spleen, lungs, and lymph nodes. Unlike T and B cells, NK cells are a type of lymphocyte that can non-specifically kill tumor cells and virus-infected cells without prior sensitization.

[0003] Because it's impossible to ensure complete alignment between in vitro culture and clinical application, and to avoid increased costs due to prolonged culture and the decline in cell growth and activity after exceeding the optimal logarithmic growth phase, which could negatively impact therapeutic quality, preserving cultured NK cells has become a necessary method. Currently, programmed cooling is commonly used for NK cell cryopreservation, but this process is cumbersome. While direct freezing at -80℃ is more popular, this method causes greater damage to NK cells during cryopreservation, significantly reducing recovery rates and post-resuscitation cytotoxic activity, thus limiting its application.

[0004] Therefore, it is particularly important to develop a preservation method that ensures the viability of NK cells after cryopreservation. Summary of the Invention

[0005] The purpose of this invention is to provide a method for improving the activity of NK cells after cryopreservation. By improving existing cryopreservation solutions and methods, a novel method for preserving NK cells is obtained, which effectively improves the activity of NK cells after cryopreservation.

[0006] To achieve the above-mentioned objectives, the present invention provides the following technical solution:

[0007] This invention provides a cryopreservation solution to improve the activity of NK cells after cryopreservation. The cryopreservation solution is based on AIM-V medium, fetal bovine serum and glycerol, and also contains the following raw materials at the following concentrations: sodium alginate 5-15 g / L, dimethyl sulfoxide 80-120 g / L, human serum albumin 20-30 mg / L, tremella polysaccharide 8-12 mg / L, and 5-glutenin-3-ol 20-30 mg / L.

[0008] Preferably, the volume ratio of AIM-V culture medium, fetal bovine serum, and glycerol in the cryopreservation solution is 7–9:1–2:0.5–1.5.

[0009] The present invention also provides the application of the cryopreservation solution in improving the activity of NK cells after cryopreservation.

[0010] The present invention also provides a method for improving the activity of NK cells after cryopreservation using the aforementioned cryopreservation solution, comprising the following steps:

[0011] (1) Take the NK cells to be frozen and mix them with the freezing solution to obtain an NK cell suspension;

[0012] (2) After centrifuging the NK cell suspension, clean NK cells were obtained;

[0013] (3) The cleaned NK cells were mixed with the cryopreservation solution to obtain the NK cell resuspension;

[0014] (4) Pre-cool the NK cell resuspension and then transfer it to a long-term cryopreservation environment.

[0015] Preferably, the density of NK cells in the NK cell suspension in step (1) is 1–4 × 10⁻⁶. 6 per mL.

[0016] Preferably, the centrifugation conditions in step (2) are 350-450g and 10-20min.

[0017] Preferably, the density of clean NK cells in the NK cell resuspension in step (3) is 1–4 × 10⁻⁶. 6 per mL.

[0018] As a preferred method, the pre-cooling method in step (4) is to let the NK cell resuspension stand at 0-4℃ for 20-40 min, and then transfer it to -15--25℃ and let it stand for 2-4 h.

[0019] Preferably, the temperature of the long-term cryopreservation environment in step (4) is -75 to -85°C.

[0020] This invention provides a method for improving the activity of NK cells after cryopreservation. The method involves a cryopreservation solution based on AIM-V medium, fetal bovine serum, and glycerol, and further containing the following concentrations of raw materials: sodium alginate 5-15 g / L, dimethyl sulfoxide 80-120 g / L, human serum albumin 20-30 mg / L, Tremella fuciformis polysaccharide 8-12 mg / L, and 5-glutenin-3-ol 20-30 mg / L. Using the NK cell cryopreservation solution provided by this invention in conjunction with the NK cell cryopreservation method of this invention can effectively improve the activity of NK cells after cryopreservation and ensure the cytotoxic effect of the cryopreserved NK cells. Detailed Implementation

[0021] This invention provides a cryopreservation solution to improve the activity of NK cells after cryopreservation. The cryopreservation solution is based on AIM-V medium, fetal bovine serum and glycerol, and also contains the following raw materials at the following concentrations: sodium alginate 5-15 g / L, dimethyl sulfoxide 80-120 g / L, human serum albumin 20-30 mg / L, tremella polysaccharide 8-12 mg / L, and 5-glutenin-3-ol 20-30 mg / L.

[0022] In this invention, the concentration of sodium alginate is preferably 8-12 g / L, and more preferably 10 g / L.

[0023] In this invention, the concentration of the dimethyl sulfoxide is preferably 90-110 g / L, and more preferably 100 g / L.

[0024] In this invention, the concentration of the human serum albumin is preferably 22-28 mg / L, and more preferably 25 mg / L.

[0025] In this invention, the concentration of the Tremella polysaccharide is preferably 9-11 mg / L, and more preferably 10 mg / L.

[0026] In this invention, the concentration of 5-glutenin-3-ol is preferably 22-28 mg / L, and more preferably 25 mg / L.

[0027] In this invention, the volume ratio of AIM-V culture medium, fetal bovine serum and glycerol in the cryopreservation solution is preferably 7-9:1-2:0.5-1.5, and more preferably 8:1.5:1.

[0028] The present invention also provides the application of the cryopreservation solution in improving the activity of NK cells after cryopreservation.

[0029] The present invention also provides a method for improving the activity of NK cells after cryopreservation using the aforementioned cryopreservation solution, comprising the following steps:

[0030] (1) Take the NK cells to be frozen and mix them with the freezing solution to obtain an NK cell suspension;

[0031] (2) After centrifuging the NK cell suspension, clean NK cells were obtained;

[0032] (3) The cleaned NK cells were mixed with the cryopreservation solution to obtain the NK cell resuspension;

[0033] (4) Pre-cool the NK cell resuspension and then transfer it to a long-term cryopreservation environment.

[0034] In this invention, the density of NK cells in the NK cell suspension in step (1) is preferably 1 to 4 × 10⁻⁶. 6 The concentration of cells / mL is more preferably 2 to 3 × 10⁻⁶. 6per mL.

[0035] In this invention, the centrifugation conditions in step (2) are preferably 350-450g and 10-20min, and more preferably 400g × 15min.

[0036] In this invention, the density of clean NK cells in the NK cell resuspension in step (3) is preferably 1 to 4 × 10⁻⁶. 6 The concentration of cells / mL is more preferably 2 to 3 × 10⁻⁶. 6 per mL.

[0037] In this invention, the pre-cooling method in step (4) is preferably: the NK cell resuspension is allowed to stand at 0-4°C for 20-40 min, and then transferred to -15--25°C for 2-4 h. More preferably: the NK cell resuspension is allowed to stand at 2°C for 30 min, and then transferred to -20°C for 3 h.

[0038] In this invention, the temperature of the long-term cryopreservation environment in step (4) is preferably -75 to -85°C, and more preferably -80°C.

[0039] The technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the scope of protection of the present invention.

[0040] Example 1

[0041] A method for enhancing the activity of NK cells after cryopreservation using the aforementioned cryopreservation solution includes the following steps:

[0042] (1) Mix AIM-V medium, fetal bovine serum and glycerol in a volume ratio of 9 parts AIM-V medium, 1 part fetal bovine serum and 0.5 parts glycerol to obtain a mixture;

[0043] (2) Add sodium alginate, dimethyl sulfoxide, human serum albumin, tremella polysaccharide and 5-glutenin-3-ol to the mixture to obtain a cryopreservation solution;

[0044] (3) Mix the NK cells to be cryopreserved with the cryopreservation solution and adjust the concentration of NK cells to 4 × 10⁻⁶. 6 NK cell suspension was obtained by averaging cells / mL;

[0045] (2) After centrifuging the NK cell suspension at 450g for 10min, clean NK cells were obtained;

[0046] (3) Mix the cleaned NK cells with the cryopreservation solution and adjust the NK cell concentration to 4 × 10⁻⁶. 6 NK cells were resuspended at 10 cells / mL.

[0047] (4) The NK cell resuspension was left to stand at 4°C for 20 min, then transferred to -15°C and left to stand for 4 h, and then transferred to -75°C for long-term cryopreservation.

[0048] Note: The concentrations of sodium alginate, dimethyl sulfoxide, human serum albumin, tremella polysaccharide, and 5-glutenin-3-ol mentioned are as follows: sodium alginate 5 g / L, dimethyl sulfoxide 120 g / L, human serum albumin 20 mg / L, tremella polysaccharide 12 mg / L, and 5-glutenin-3-ol 30 mg / L.

[0049] Example 2

[0050] A method for enhancing the activity of NK cells after cryopreservation using the aforementioned cryopreservation solution includes the following steps:

[0051] (1) Mix AIM-V medium, fetal bovine serum and glycerol in a volume ratio of 7 parts AIM-V medium, 2 parts fetal bovine serum and 1.5 parts glycerol to obtain a mixture;

[0052] (2) Add sodium alginate, dimethyl sulfoxide, human serum albumin, tremella polysaccharide and 5-glutenin-3-ol to the mixture to obtain a cryopreservation solution;

[0053] (3) Mix the NK cells to be cryopreserved with the cryopreservation solution and adjust the concentration of NK cells to 1×10⁻⁶. 6 NK cell suspension was obtained by averaging cells / mL;

[0054] (2) After centrifuging the NK cell suspension at 350g for 20min, clean NK cells were obtained;

[0055] (3) Mix the cleaned NK cells with the cryopreservation solution and adjust the NK cell concentration to 1×10⁻⁶. 6 NK cells were resuspended at 10 cells / mL.

[0056] (4) The NK cell resuspension was left to stand at 0°C for 40 min, then transferred to 25°C and left to stand for 2 h, and then transferred to -85°C for long-term cryopreservation.

[0057] Note: The concentrations of sodium alginate, dimethyl sulfoxide, human serum albumin, tremella polysaccharide, and 5-glutenin-3-ol mentioned are as follows: sodium alginate 15 g / L, dimethyl sulfoxide 80 g / L, human serum albumin 30 mg / L, tremella polysaccharide 8 mg / L, and 5-glutenin-3-ol 20 mg / L.

[0058] Example 3

[0059] A method for enhancing the activity of NK cells after cryopreservation using the aforementioned cryopreservation solution includes the following steps:

[0060] (1) Mix AIM-V medium, fetal bovine serum and glycerol in a volume ratio of 8 parts AIM-V medium, 1.5 parts fetal bovine serum and 1 part glycerol to obtain a mixture;

[0061] (2) Add sodium alginate, dimethyl sulfoxide, human serum albumin, tremella polysaccharide and 5-glutenin-3-ol to the mixture to obtain a cryopreservation solution;

[0062] (3) Mix the NK cells to be cryopreserved with the cryopreservation solution and adjust the concentration of NK cells to 2×10⁻⁶. 6 NK cell suspension was obtained by averaging cells / mL;

[0063] (2) After centrifuging the NK cell suspension at 400g for 15min, clean NK cells were obtained;

[0064] (3) Mix the cleaned NK cells with the cryopreservation solution and adjust the NK cell concentration to 2×10⁻⁶. 6 NK cells were resuspended at 10 cells / mL.

[0065] (4) The NK cell resuspension was left to stand at 2°C for 30 min, then transferred to -20°C and left to stand for 3 h, and then transferred to -80°C for long-term cryopreservation.

[0066] Note: The concentrations of sodium alginate, dimethyl sulfoxide, human serum albumin, tremella polysaccharide, and 5-glutenin-3-ol mentioned are as follows: sodium alginate 10 g / L, dimethyl sulfoxide 100 g / L, human serum albumin 25 mg / L, tremella polysaccharide 10 mg / L, and 5-glutenin-3-ol 25 mg / L.

[0067] Test case

[0068] 1. Cell viability detection

[0069] Commercially available NK cells were divided into five equal parts, and each part was prepared into NK cell densities of 1×10⁶ cells using SCGM medium containing 300 U / ml IL-2 and 10% human AB plasma. 6 Suspensions of NK cells per mL were numbered as experimental group samples 1-3 and control group samples 1-2. The viability of NK cells in control group sample 1 was detected and recorded using trypan blue staining.

[0070] Sample 1 in the experimental group was cryopreserved using the method of Example 1, sample 2 in the experimental group was cryopreserved using the method of Example 2, and sample 3 in the experimental group was cryopreserved using the method of Example 3. Sample 2 in the control group was incubated at 2°C for 30 min, then transferred to -20°C for 3 h, and then cryopreserved at -80°C.

[0071] Samples 1-3 from the experimental groups and sample 2 from the control group were cryopreserved for 28 weeks. After cryopreservation, samples 1-3 from the experimental groups and sample 2 from the control group were removed, thawed in a water bath at 37°C, centrifuged at 400g for 15 min, and the culture medium was removed. The samples were then resuspended in SCGM medium containing 300 U / ml IL-2 and 10% human AB plasma to prepare NK cells with a density of 1×10⁻⁶ cells / mL. 6 The suspension was prepared at a concentration of 10 cells / mL. The viability of NK cells in the resuspended experimental samples 1–3 and control sample 2 was then detected and recorded using trypan blue staining. The results are shown in Table 1.

[0072] Table 1

[0073] Group Cell viability Unfrozen control group sample 1 94.3% Control group sample 2 after cryopreservation 68.8% Sample 1 of the experimental group after cryopreservation 92.8% Sample 2 of the experimental group after freezing 91.9% Sample 3 of the experimental group after cryopreservation 91.6%

[0074] Results: The cell viability of the unfrozen control group 1 was used as the initial viability of commercially available NK cells. Although control group sample 2 underwent cryopreservation, it was only treated with conventional culture medium, which did not achieve a good cryopreservation effect. In contrast, the cell viability of experimental groups 1-3 did not decrease significantly after cryopreservation.

[0075] 2. Cell killing effect test

[0076] Take the unfrozen control group sample 1, the thawed control group sample 2 from 1 above, and the thawed experimental group samples 1-3, and respectively mix them with a suspension of gastric cancer MKN45 cells in the logarithmic growth phase (the density of gastric cancer MKN45 cells is 1×10⁻⁶). 5 The mixture was prepared with 10:1 effective-to-target ratio (1 molecule / mL) and cultured for 4 h. The killing effect was detected by lactate dehydrogenase release method. The results are shown in Table 2.

[0077] Group Cell killing effect Unfrozen control group sample 1 48.6% Control group sample 2 after cryopreservation 33.7% Sample 1 of the experimental group after freezing 46.1% Sample 2 of the experimental group after freezing 45.8% Sample 3 of the experimental group after cryopreservation 46.4%

[0078] Results: The NK cell cryopreservation solution provided by this invention, combined with the NK cell cryopreservation method of this invention, can effectively improve the killing effect of NK cells after cryopreservation.

[0079] As can be seen from the above embodiments, the present invention provides a method for improving the activity of NK cells after cryopreservation. This method involves a cryopreservation solution based on AIM-V culture medium, fetal bovine serum, and glycerol, and further containing the following concentrations of raw materials: sodium alginate 5-15 g / L, dimethyl sulfoxide 80-120 g / L, human serum albumin 20-30 mg / L, Tremella fuciformis polysaccharide 8-12 mg / L, and 5-glutenin-3-ol 20-30 mg / L. Using the NK cell cryopreservation solution provided by the present invention in conjunction with the NK cell cryopreservation method of the present invention can effectively improve the activity of NK cells after cryopreservation and ensure the killing effect of cryopreserved NK cells.

[0080] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.

Claims

1. A cryopreservation solution for improving the activity of NK cells after cryopreservation, It is characterized in that The freezing solution is based on AIM-V culture medium, calf serum and glycerol, and also contains the following raw materials in the following concentrations: 5-15 g / L sodium alginate, 80-120 g / L dimethyl sulfoxide, 20-30 mg / L human serum albumin, 8-12 mg / L tremella polysaccharide, and 20-30 mg / L 5-glutenin-3-ol.

2. The cryopreservation solution according to claim 1, It is characterized in that The volume ratio of AIM-V culture medium, calf serum and glycerol in the freezing solution is 7-9:1-2:0.5-1.

5.

3. Use of the cryopreservation solution according to claim 1 or 2 in improving the activity of NK cells after cryopreservation.

4. A method for improving the activity of NK cells after cryopreservation using the cryopreservation solution according to claim 1 or 2, It is characterized in that The steps include: (1) Mixing the NK cells to be frozen with a freezing solution to obtain a NK cell suspension; (2) After centrifuging the NK cell suspension, clean NK cells are obtained; (3) mixing the clean NK cells with the freezing solution to obtain a NK cell resuspension; (4) Precool the NK cell resuspension and then transfer it to a long-term freezing environment.

5. The method according to claim 4, It is characterized in that The density of NK cells in the NK cell suspension in step (1) is 1 to 4×10 6 Pieces / mL.

6. The method according to claim 5, It is characterized in that The centrifugal conditions in step (2) are 350-450 g and 10-20 min.

7. The method according to claim 6, It is characterized in that The density of clean NK cells in the NK cell resuspension in step (3) is 1 to 4×10 6 Pieces / mL.

8. The method according to claim 7, It is characterized in that The precooling method in step (4) is: the NK cell resuspension is allowed to stand at 0 to 4°C for 20 to 40 minutes, and then transferred to -15 to -25°C and allowed to stand for 2 to 4 hours.

9. The method according to any one of claims 4 to 8, It is characterized in that The temperature of the long-term freezing environment in step (4) is -75 to -85°C.